ES2190476T3 - Agentes endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su obtencion. - Google Patents
Agentes endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su obtencion.Info
- Publication number
- ES2190476T3 ES2190476T3 ES96927634T ES96927634T ES2190476T3 ES 2190476 T3 ES2190476 T3 ES 2190476T3 ES 96927634 T ES96927634 T ES 96927634T ES 96927634 T ES96927634 T ES 96927634T ES 2190476 T3 ES2190476 T3 ES 2190476T3
- Authority
- ES
- Spain
- Prior art keywords
- didepsipeptides
- procedure
- new
- endoparasiticid
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/58—Y being a hetero atom
- C07C275/62—Y being a nitrogen atom, e.g. biuret
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/48—Y being a hydrogen or a carbon atom
- C07C275/50—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
LA PRESENTE INVENCION TRATA DEL EMPLEO DE DIDEPSIPEPTIDOS DE FORMULA GENERAL (I) Y DE SUS SALES, ASI COMO DE NUEVOS DIDEPSIPEPTIDOS Y DEL PROCEDIMIENTO PARA LA PREPARACION DE LOS MISMOS. EN LA FORMULA (I) LOS RADICALES POSEEN LA SIGNIFICACION DADA EN LA DESCRIPCION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19529604A DE19529604A1 (de) | 1995-08-11 | 1995-08-11 | Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2190476T3 true ES2190476T3 (es) | 2003-08-01 |
Family
ID=7769288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96927634T Expired - Lifetime ES2190476T3 (es) | 1995-08-11 | 1996-07-30 | Agentes endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su obtencion. |
Country Status (26)
Country | Link |
---|---|
US (2) | US20020142969A1 (es) |
EP (1) | EP0843658B1 (es) |
JP (3) | JPH11511142A (es) |
KR (1) | KR19990036304A (es) |
CN (2) | CN1053657C (es) |
AR (1) | AR003977A1 (es) |
AT (1) | ATE229933T1 (es) |
AU (1) | AU707123B2 (es) |
BG (1) | BG64091B1 (es) |
BR (1) | BRPI9610049B1 (es) |
CA (1) | CA2228939C (es) |
CZ (1) | CZ41698A3 (es) |
DE (2) | DE19529604A1 (es) |
DK (1) | DK0843658T3 (es) |
ES (1) | ES2190476T3 (es) |
HK (1) | HK1017340A1 (es) |
HU (1) | HUP9802316A3 (es) |
MX (1) | MX9801133A (es) |
NO (1) | NO311566B1 (es) |
NZ (1) | NZ315642A (es) |
PL (1) | PL187412B1 (es) |
SK (1) | SK15598A3 (es) |
TR (1) | TR199800210T2 (es) |
TW (1) | TW492976B (es) |
WO (1) | WO1997007093A1 (es) |
ZA (1) | ZA966749B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458772B1 (en) | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
DE19962145A1 (de) | 1999-12-22 | 2001-06-28 | Bayer Ag | Schädlingsbekämpfungsmittel/Depsipeptide |
DE19962147A1 (de) | 1999-12-22 | 2001-06-28 | Bayer Ag | Schädlingsbekämpfungsmittel / PF 1022-221 |
BRPI0620659A2 (pt) | 2005-12-09 | 2017-10-31 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | método para a prevenção do aparecimento de sintomas de uma doença neurodegenerativa em um indivíduo predisposto à doença neurodegenerativa, método de redução de stress oxidante no cérebro de um indivíduo afligido com stress oxidante, método de tratamento de um indivíduo afligido com a degeneração cognitiva suave e composição farmacêutica |
TW200744576A (en) | 2006-02-24 | 2007-12-16 | Teva Pharma | Propargylated aminoindans, processes for preparation, and uses thereof |
WO2009070631A2 (en) * | 2007-11-28 | 2009-06-04 | University Of Virginia Patent Foundation | Ethoid compounds for use as food additives |
TW200938203A (en) * | 2007-12-17 | 2009-09-16 | Intervet Int Bv | Anthelmintic agents and their use |
TW201111358A (en) | 2009-06-18 | 2011-04-01 | Intervet Int Bv | Anthelmintic agents and their use |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2619247C2 (de) * | 1976-04-30 | 1986-04-03 | Eckert, Heiner, Dipl.-Chem. Dr., 8000 München | Verfahren zum Schutze reaktionsfähiger Amino-, Hydroxyl- und/oder Carboxylgruppen |
FR2365341A1 (fr) * | 1976-09-28 | 1978-04-21 | Synthelabo | Derives de l'acide l-(phenyl-3 amino-2 propionyloxy)-2 acetique |
HU181008B (en) * | 1980-01-18 | 1983-05-30 | Richter Gedeon Vegyeszet | Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position |
JPS606649A (ja) * | 1983-06-24 | 1985-01-14 | Daicel Chem Ind Ltd | モノマ− |
DK406686D0 (da) * | 1986-08-26 | 1986-08-26 | Hans Bundgaard | Carboxylsyrederivater |
WO1993019053A1 (fr) * | 1992-03-17 | 1993-09-30 | Fujisawa Pharmaceutical Co., Ltd. | Derive de depsipeptide, production et utilisation |
DE4317458A1 (de) * | 1992-06-11 | 1993-12-16 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung |
CN1073560C (zh) * | 1993-02-19 | 2001-10-24 | 明治制果株式会社 | 环缩酚酸肽pf1022衍生物 |
DE4317457A1 (de) * | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
DE4341992A1 (de) * | 1993-12-09 | 1995-06-14 | Bayer Ag | Endoparasitizide Mittel auf Basis von offenkettigen Tetradepsipeptiden |
DE4341991A1 (de) * | 1993-12-09 | 1995-06-14 | Bayer Ag | Endoparasitizide Mittel auf Basis von offenkettigen Hexadepsipeptiden |
-
1995
- 1995-08-11 DE DE19529604A patent/DE19529604A1/de not_active Withdrawn
-
1996
- 1996-07-30 AU AU67394/96A patent/AU707123B2/en not_active Expired
- 1996-07-30 TR TR1998/00210T patent/TR199800210T2/xx unknown
- 1996-07-30 MX MX9801133A patent/MX9801133A/es unknown
- 1996-07-30 PL PL96324893A patent/PL187412B1/pl not_active IP Right Cessation
- 1996-07-30 HU HU9802316A patent/HUP9802316A3/hu unknown
- 1996-07-30 SK SK155-98A patent/SK15598A3/sk unknown
- 1996-07-30 CZ CZ98416A patent/CZ41698A3/cs unknown
- 1996-07-30 US US09/011,599 patent/US20020142969A1/en not_active Abandoned
- 1996-07-30 DE DE59610011T patent/DE59610011D1/de not_active Expired - Lifetime
- 1996-07-30 DK DK96927634T patent/DK0843658T3/da active
- 1996-07-30 KR KR1019980700972A patent/KR19990036304A/ko not_active Application Discontinuation
- 1996-07-30 CA CA002228939A patent/CA2228939C/en not_active Expired - Lifetime
- 1996-07-30 WO PCT/EP1996/003355 patent/WO1997007093A1/de not_active Application Discontinuation
- 1996-07-30 JP JP9508872A patent/JPH11511142A/ja active Pending
- 1996-07-30 EP EP96927634A patent/EP0843658B1/de not_active Expired - Lifetime
- 1996-07-30 BR BRPI9610049A patent/BRPI9610049B1/pt not_active IP Right Cessation
- 1996-07-30 ES ES96927634T patent/ES2190476T3/es not_active Expired - Lifetime
- 1996-07-30 AT AT96927634T patent/ATE229933T1/de not_active IP Right Cessation
- 1996-07-30 NZ NZ315642A patent/NZ315642A/xx not_active IP Right Cessation
- 1996-07-30 CN CN96197521A patent/CN1053657C/zh not_active Expired - Fee Related
- 1996-08-05 TW TW085109422A patent/TW492976B/zh not_active IP Right Cessation
- 1996-08-08 ZA ZA9606749A patent/ZA966749B/xx unknown
- 1996-08-09 AR ARP960103941A patent/AR003977A1/es not_active Application Discontinuation
-
1998
- 1998-01-26 NO NO19980324A patent/NO311566B1/no not_active IP Right Cessation
- 1998-01-28 BG BG102213A patent/BG64091B1/bg unknown
-
1999
- 1999-05-05 HK HK99102025A patent/HK1017340A1/xx not_active IP Right Cessation
- 1999-09-09 CN CN99118744A patent/CN1254596A/zh active Pending
-
2002
- 2002-11-08 US US10/290,827 patent/US7772190B2/en not_active Expired - Fee Related
-
2010
- 2010-05-10 JP JP2010108807A patent/JP2010222361A/ja not_active Withdrawn
-
2014
- 2014-04-11 JP JP2014082229A patent/JP2014159449A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2138691T3 (es) | Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina. | |
CO4750588A1 (es) | Bifenilamidas | |
AR010062A1 (es) | Nuevos benzamidaldehidos y su utilizacion | |
ES2157027T3 (es) | Oxazolidinonas sustituidas y su uso como farmacos antibacterianos. | |
GT199900215A (es) | Formulaciones agroquimicas. | |
AR023727A1 (es) | Compuestos empleados en el tratamiento de padecimientos inflamatorios | |
ES2196054T3 (es) | Derivados de acido fenilacetico, procedimiento y productos intermedios para su obtencion y agentes que contienen los mismos. | |
ES2137628T3 (es) | Derivados de estilbeno y composiciones farmaceuticas que los contienen. | |
CY1109153T1 (el) | Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης | |
ES2183331T3 (es) | Inhibidores de sulfamida-metaloproteasa. | |
ES2179337T3 (es) | Disulfuros de triazolilo. | |
AR007770A1 (es) | Nuevos diamino pirazoles, su sintesis, composiciones de tintura de fibras queratinicas que los contienen, procedimientos de tintura de fibrasqueratinicas. | |
ES2190476T3 (es) | Agentes endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su obtencion. | |
ES2043665T3 (es) | 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso. | |
ECSP034813A (es) | Arilsulfonamidas como agentes antivirales | |
AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
ES2111715T3 (es) | Marcadores extraibles mediante una base para productos petroliferos. | |
DK0756602T3 (da) | CCK- eller gastrin-modulerende 5-heterocyclo-1,5-benzodiazepiner | |
AR025796A1 (es) | Quinazolinonas | |
ES2151991T3 (es) | Procedimiento para preparar un derivado de tieno(2,3-b)(1,5)benzodiacepina. | |
MX9305773A (es) | 5-oxo-dibenzo/a,d/ciclohepta-1,4-dienos, procedimiento para su obtencion y medicamentos que los contienen. | |
ES2125537T3 (es) | Arilbenzoilguanidinas. | |
ES2136628T3 (es) | 4-iminoquinolinas, procedimiento para su preparacion y su empleo. | |
ES2193248T3 (es) | Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea. | |
PA8477601A1 (es) | Inhibidores de las fkbp |